LKBL208 project
11 Abr 23
LKBL208 LKBL208 Tratamiento dirigido del cáncer de mama triple negativo con un nuevo antagonista oral del receptor de serotonina 1B
LKBL208 LKBL208 Tratamiento dirigido del cáncer de mama triple negativo con un nuevo antagonista oral del receptor de serotonina 1B
iDIABETES Project iDIABETES New digital tools for remote, non-invasive and continuous diagnosis for chronic diabetic patients ABSTRACT As it is
Colaboración publico-privada para el diagnóstico del cáncer basado en biopsia líquida e Inteligencia Artificial Flomics Biotech, en colaboración con el
3D ONCOCHIP Tumour-on-chip: one-person-trial for drug efficacy The project aims at developing up-scalable and standardized tumor-on-chip offering high-level in-vitro human
RTC MICROINMUNOMAMA Breast cancer is the second leading cause of death in women and accounts for 11% of cancers detected
RAADiCal The objective of the project is to help elderly or disabled people to maintain a healthy mental and physical
Stem Cell NanoImaging – Advances and Applications Conference nTRACK Open Day Workshop 2022 Announcement Location: ONLINE Date: 14th March 2022
HELLOAI RIS ONLINE JOIN THE BEST CROSS-SECTORIAL ONLINE EDUCATION PROGRAMME ON AI SOLUTIONS FOR SOLVING MEDICAL IMAGING CHALLENGES. HelloAI RIS
Abstract: The spread of bacterial infections resistant to antibiotics is one of the big threats of public health. Mortality, morbidity-,
Abstract: Background: Detection of autoantibodies in the clinical laboratory has been a powerful tool widely used in the diagnosis and
The €6.1 million project INNO4COV-19 is committed to supporting the commercialization of new products across Europe for combating COVID-19 over
On the 29th of May, the OActive project organised a training session for potential end-users entitled “Engaging end users to
The final event for the EIT Health project INFINITy will take place the 26th of June in an online format.
OActive project is pleased to invite you to the training session:«Engaging end users to the OActive world», which will be
CataloniaBio & HealthTech’s Regulatory Affairs Working Group organizes the sixth Hard Reg Cafè under the title Experiences and exceptional procedures
The international consortium, together with the AIRR Community, is now in the process of mapping the different initiatives producing data
Sede Central Leitat
C/ de la Innovació, 2
08225 Terrassa, (Barcelona)
Tel. (+34) 937 882 300
